With the proposed BIOSECURE Act in the US having moved to the Senate for a vote since the US House of Representatives passed related bill HR 8333 on 9 September, there is still lingering uncertainty over whether it will actually be signed into law and when.
The fate of the planned legislation, which stands to restrict US industry dealings with selected Chinese contract manufacturing and services...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?